Lars Palmowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lars Palmowski has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Hartmuth Nowak
Ruhr University Bochum, Knappschaft Kliniken University Hospital Bochum, Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Bochum, Germany
11 shared publications - Michael Adamzik
Ruhr University Bochum, Knappschaft Kliniken Universitätsklinikum Bochum, Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätstraße 150, Bochum, Germany, 49 02343229242
9 shared publications - Frank Martin Brunkhorst
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena, Jena, Deutschland
7 shared publications - Godwin Denk Giebel
University of Duisburg-Essen
7 shared publications - Jürgen Wasem
Institute of Healthcare Management, Universität Duisburg-Essen, 45127 Essen, Germany
7 shared publications - Marianne Tokic
Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, Bochum, Germany
7 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e87020
AI-Supported, Integrative Prediction of Postoperative Delirium: Protocol for the CONFUSED Study
Background: Postoperative delirium (POD) is a frequent and serious complication in older surgical patients, characterized by acute cognitive dysfunction and fluctuating levels of consciousness. POD is associated with prolonged hospitalization, long-term cognitive decline, reduced quality of life, and increased mortality. Despite its clinical relevance, the underlying pathophysiological mechanisms remain poorly understood, and reliable biomarkers for early prediction and prevention are lacking. Objective: The CONFUSED study aims to identify molecular and clinical predictors of POD by integrating clinical data with proteomic, transcriptomic, and epigenetic analyses. The primary objective is to develop predictive models for POD using multimodal data. Secondary objectives include the identification of delirium-associated genes, proteins, and epigenetic signatures, as well as the exploration of patient subgroups at increased risk for POD. Methods: CONFUSED is a prospective observational cohort study conducted at a German university hospital. Adult patients undergoing major surgery under general anesthesia will be enrolled until 100 cases of POD have been observed, which is expected to require a total sample size of approximately 200 to 300 patients. Blood samples are collected at 4 predefined time points: before premedication, immediately after surgery, and on postoperative days 2 and 5. Samples undergo comprehensive proteomic profiling, transcriptomic analysis using RNA microarrays, DNA methylation analysis, and genotyping of selected polymorphisms. Clinical data, including demographics, comorbidities, perioperative variables, medications, and delirium assessments using the Confusion Assessment Method (CAM) and CAM for the intensive care unit, are systematically recorded. Statistical analyses include univariate and multivariate methods, as well as machine learning approaches such as random forests and support vector machines, to identify relevant biomarkers and develop predictive models. The study protocol follows STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) and TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) guidelines and was approved by the responsible ethics committees. Results: The study was registered in the German Clinical Trials Register (DRKS00033854) on March 18, 2024. Recruitment started in January 2024 and is ongoing at the time of manuscript submission. As of now, 135 patients have been enrolled. Sample collection and laboratory analyses are ongoing. Data analysis began in January 2026, with first results anticipated in July 2026. Final data lock is anticipated after the completion of recruitment. Conclusions: By integrating multimodal molecular data with clinical parameters and applying advanced machine learning techniques, the CONFUSED study aims to improve the prediction and understanding of POD. The results are expected to support the development of personalized preventive strategies and contribute to improved perioperative care for patients at risk of POD.
- 25 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e87020
Open AccessAI-Supported, Integrative Prediction of Postoperative Delirium: Protocol for the CONFUSED Study
Background: Postoperative delirium (POD) is a frequent and serious complication in older surgical patients, characterized by acute cognitive dysfunction and fluctuating levels of consciousness. POD is associated with prolonged hospitalization, long-term cognitive decline, reduced quality of life, and increased mortality. Despite its clinical relevance, the underlying pathophysiological mechanisms remain poorly understood, and reliable biomarkers for early prediction and prevention are lacking. Objective: The CONFUSED study aims to identify molecular and clinical predictors of POD by integrating clinical data with proteomic, transcriptomic, and epigenetic analyses. The primary objective is to develop predictive models for POD using multimodal data. Secondary objectives include the identification of delirium-associated genes, proteins, and epigenetic signatures, as well as the exploration of patient subgroups at increased risk for POD. Methods: CONFUSED is a prospective observational cohort study conducted at a German university hospital. Adult patients undergoing major surgery under general anesthesia will be enrolled until 100 cases of POD have been observed, which is expected to require a total sample size of approximately 200 to 300 patients. Blood samples are collected at 4 predefined time points: before premedication, immediately after surgery, and on postoperative days 2 and 5. Samples undergo comprehensive proteomic profiling, transcriptomic analysis using RNA microarrays, DNA methylation analysis, and genotyping of selected polymorphisms. Clinical data, including demographics, comorbidities, perioperative variables, medications, and delirium assessments using the Confusion Assessment Method (CAM) and CAM for the intensive care unit, are systematically recorded. Statistical analyses include univariate and multivariate methods, as well as machine learning approaches such as random forests and support vector machines, to identify relevant biomarkers and develop predictive models. The study protocol follows STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) and TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) guidelines and was approved by the responsible ethics committees. Results: The study was registered in the German Clinical Trials Register (DRKS00033854) on March 18, 2024. Recruitment started in January 2024 and is ongoing at the time of manuscript submission. As of now, 135 patients have been enrolled. Sample collection and laboratory analyses are ongoing. Data analysis began in January 2026, with first results anticipated in July 2026. Final data lock is anticipated after the completion of recruitment. Conclusions: By integrating multimodal molecular data with clinical parameters and applying advanced machine learning techniques, the CONFUSED study aims to improve the prediction and understanding of POD. The results are expected to support the development of personalized preventive strategies and contribute to improved perioperative care for patients at risk of POD.
- Open Access
- 26 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e76772
Patient Benefits in the Context of Sepsis-Related AI-Based Clinical Decision Support Systems: Scoping Review
Background: Global digitalization continues to advance, extending its influence into medicine and health care systems worldwide. In recent years, substantial advancements have been made in the research and development of artificial intelligence (AI), raising questions about its potential in medicine. The integration and application of AI in intensive care medicine, particularly in sepsis treatment, presents significant potential for advancing patient outcomes and enhancing patient-relevant benefits. However, a comprehensive and systematic overview of the full spectrum of patient-relevant benefits associated with AI-based clinical decision support systems (CDSS) remains lacking. Objective: This scoping review aimed to identify and categorize evidence on patient-relevant benefits of AI-based CDSS in sepsis care. Methods: Systematic research was conducted in 4 electronic databases: MEDLINE via PubMed, Embase, the ACM Digital Library, and IEEE Xplore. In addition, a comprehensive search on the websites of relevant international organizations, along with a citation search of the included articles, was conducted. Articles were included if they (1) focused on sepsis and (2) described patient-relevant benefits of AI-based CDSS. Articles published between January 1, 2008, and March 2, 2023, were considered for inclusion. Study selection was performed independently by 2 reviewers. The manuscript was drafted in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist. The analysis of the included articles was conducted using the program MAXQDA (VERBI Software GmbH), with systemization finalized in a consensus workshop. Results: A total of 3368 records were identified across the 4 databases, of which 24 met the inclusion criteria and were included in the scoping review. The additional search on international websites and in reference lists identified 6 more relevant articles, resulting in 30 included studies. Of these, 20 were quantitative, comprising 7 prospective and 13 retrospective designs. In addition, 1 qualitative study, 1 mixed methods study, 6 review articles, and 2 articles from institutional websites were included. Patient-relevant benefits were systematized in six main categories: (1) prediction, (2) earlier treatment and prioritization of high-risk patients, (3) individualized therapy, (4) improved patient outcomes (including improved Sequential Organ Failure Assessment score, reduced length of stay, and reduced mortality), (5) general improvements in care, and (6) reduced readmission rate. Conclusions: This scoping review underscores the potential of AI-based CDSS to positively impact patient-relevant benefits, particularly in sepsis care, where they demonstrate considerable promise for improving intensive care. However, the majority of the identified studies rely on retrospective database analyses. Future research should focus on validating these findings through prospective studies.
- 26 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e76772
Open AccessPatient Benefits in the Context of Sepsis-Related AI-Based Clinical Decision Support Systems: Scoping Review
Background: Global digitalization continues to advance, extending its influence into medicine and health care systems worldwide. In recent years, substantial advancements have been made in the research and development of artificial intelligence (AI), raising questions about its potential in medicine. The integration and application of AI in intensive care medicine, particularly in sepsis treatment, presents significant potential for advancing patient outcomes and enhancing patient-relevant benefits. However, a comprehensive and systematic overview of the full spectrum of patient-relevant benefits associated with AI-based clinical decision support systems (CDSS) remains lacking. Objective: This scoping review aimed to identify and categorize evidence on patient-relevant benefits of AI-based CDSS in sepsis care. Methods: Systematic research was conducted in 4 electronic databases: MEDLINE via PubMed, Embase, the ACM Digital Library, and IEEE Xplore. In addition, a comprehensive search on the websites of relevant international organizations, along with a citation search of the included articles, was conducted. Articles were included if they (1) focused on sepsis and (2) described patient-relevant benefits of AI-based CDSS. Articles published between January 1, 2008, and March 2, 2023, were considered for inclusion. Study selection was performed independently by 2 reviewers. The manuscript was drafted in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist. The analysis of the included articles was conducted using the program MAXQDA (VERBI Software GmbH), with systemization finalized in a consensus workshop. Results: A total of 3368 records were identified across the 4 databases, of which 24 met the inclusion criteria and were included in the scoping review. The additional search on international websites and in reference lists identified 6 more relevant articles, resulting in 30 included studies. Of these, 20 were quantitative, comprising 7 prospective and 13 retrospective designs. In addition, 1 qualitative study, 1 mixed methods study, 6 review articles, and 2 articles from institutional websites were included. Patient-relevant benefits were systematized in six main categories: (1) prediction, (2) earlier treatment and prioritization of high-risk patients, (3) individualized therapy, (4) improved patient outcomes (including improved Sequential Organ Failure Assessment score, reduced length of stay, and reduced mortality), (5) general improvements in care, and (6) reduced readmission rate. Conclusions: This scoping review underscores the potential of AI-based CDSS to positively impact patient-relevant benefits, particularly in sepsis care, where they demonstrate considerable promise for improving intensive care. However, the majority of the identified studies rely on retrospective database analyses. Future research should focus on validating these findings through prospective studies.
- Top Cited PapersOpen Access
- 7 July 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e69688
Improving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders
Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems. International Registered Report Identifier (IRRID): RR2-10.2196/62704
- 7 July 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e69688
Top Cited PapersOpen AccessImproving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders
Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems. International Registered Report Identifier (IRRID): RR2-10.2196/62704
- Open Access
- 29 March 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103173
Subphenotypes and the De Ritis ratio for mortality risk stratification in sepsis-associated acute liver injury: a retrospective cohort study
- 29 March 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103173
Open AccessSubphenotypes and the De Ritis ratio for mortality risk stratification in sepsis-associated acute liver injury: a retrospective cohort study
- Top Cited PapersOpen Access
- 3 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e63377
Problems and Barriers Related to the Use of AI-Based Clinical Decision Support Systems: Interview Study
Background: Digitalization is currently revolutionizing health care worldwide. A promising technology in this context is artificial intelligence (AI). The application of AI can support health care providers in their daily work in various ways. The integration of AI is particularly promising in clinical decision support systems (CDSSs). While the opportunities of this technology are numerous, the problems should not be overlooked. Objective: This study aimed to identify challenges and barriers in the context of AI-based CDSSs from the perspectives of experts across various disciplines. Methods: Semistructured expert interviews were conducted with different stakeholders. These included representatives of patients, physicians and caregivers, developers of AI-based CDSSs, researchers (studying AI in health care and social and health law), quality management and quality assurance representatives, a representative of an ethics committee, a representative of a health insurance fund, and medical product consultants. The interviews took place on the web and were recorded, transcribed, and subsequently subjected to a qualitative content analysis based on the method by Kuckartz. The analysis was conducted using MAXQDA software. Initially, the problems were separated into “general,” “development,” and “clinical use.” Finally, a workshop within the project consortium served to systematize the identified problems. Results: A total of 15 expert interviews were conducted, and 309 expert statements with reference to problems and barriers in the context of AI-based CDSSs were identified. These emerged in 7 problem categories: technology (46/309, 14.9%), data (59/309, 19.1%), user (102/309, 33%), studies (17/309, 5.5%), ethics (20/309, 6.5%), law (33/309, 10.7%), and general (32/309, 10.4%). The problem categories were further divided into problem areas, which in turn comprised the respective problems. Conclusions: A large number of problems and barriers were identified in the context of AI-based CDSSs. These can be systematized according to the point at which they occur (“general,” “development,” and “clinical use”) or according to the problem category (“technology,” “data,” “user,” “studies,” “ethics,” “law,” and “general”). The problems identified in this work should be further investigated. They can be used as a basis for deriving solutions to optimize development, acceptance, and use of AI-based CDSSs. International Registered Report Identifier (IRRID): RR2-10.2196/preprints.62704
- 3 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e63377
Top Cited PapersOpen AccessProblems and Barriers Related to the Use of AI-Based Clinical Decision Support Systems: Interview Study
Background: Digitalization is currently revolutionizing health care worldwide. A promising technology in this context is artificial intelligence (AI). The application of AI can support health care providers in their daily work in various ways. The integration of AI is particularly promising in clinical decision support systems (CDSSs). While the opportunities of this technology are numerous, the problems should not be overlooked. Objective: This study aimed to identify challenges and barriers in the context of AI-based CDSSs from the perspectives of experts across various disciplines. Methods: Semistructured expert interviews were conducted with different stakeholders. These included representatives of patients, physicians and caregivers, developers of AI-based CDSSs, researchers (studying AI in health care and social and health law), quality management and quality assurance representatives, a representative of an ethics committee, a representative of a health insurance fund, and medical product consultants. The interviews took place on the web and were recorded, transcribed, and subsequently subjected to a qualitative content analysis based on the method by Kuckartz. The analysis was conducted using MAXQDA software. Initially, the problems were separated into “general,” “development,” and “clinical use.” Finally, a workshop within the project consortium served to systematize the identified problems. Results: A total of 15 expert interviews were conducted, and 309 expert statements with reference to problems and barriers in the context of AI-based CDSSs were identified. These emerged in 7 problem categories: technology (46/309, 14.9%), data (59/309, 19.1%), user (102/309, 33%), studies (17/309, 5.5%), ethics (20/309, 6.5%), law (33/309, 10.7%), and general (32/309, 10.4%). The problem categories were further divided into problem areas, which in turn comprised the respective problems. Conclusions: A large number of problems and barriers were identified in the context of AI-based CDSSs. These can be systematized according to the point at which they occur (“general,” “development,” and “clinical use”) or according to the problem category (“technology,” “data,” “user,” “studies,” “ethics,” “law,” and “general”). The problems identified in this work should be further investigated. They can be used as a basis for deriving solutions to optimize development, acceptance, and use of AI-based CDSSs. International Registered Report Identifier (IRRID): RR2-10.2196/preprints.62704
- Open Access
- 30 January 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e62704
User-Oriented Requirements for Artificial Intelligence–Based Clinical Decision Support Systems in Sepsis: Protocol for a Multimethod Research Project
Background: Artificial intelligence (AI)–based clinical decision support systems (CDSS) have been developed for several diseases. However, despite the potential to improve the quality of care and thereby positively impact patient-relevant outcomes, the majority of AI-based CDSS have not been adopted in standard care. Possible reasons for this include barriers in the implementation and a nonuser-oriented development approach, resulting in reduced user acceptance. Objective: This research project has 2 objectives. First, problems and corresponding solutions that hinder or support the development and implementation of AI-based CDSS are identified. Second, the research project aims to increase user acceptance by creating a user-oriented requirement profile, using the example of sepsis. Methods: The research project is based on a multimethod approach combining (1) a scoping review, (2) focus groups with physicians and professional caregivers, and (3) semistructured interviews with relevant stakeholders. The research modules mentioned provide the basis for the development of a (4) survey, including a discrete choice experiment (DCE) with physicians. A minimum of 6667 physicians with expertise in the clinical picture of sepsis are contacted for this purpose. The survey is followed by the development of a requirement profile for AI-based CDSS and the derivation of policy recommendations for action, which are evaluated in a (5) expert roundtable discussion. Results: The multimethod research project started in November 2022. It provides an overview of the barriers and corresponding solutions related to the development and implementation of AI-based CDSS. Using sepsis as an example, a user-oriented requirement profile for AI-based CDSS is developed. The scoping review has been concluded and the qualitative modules have been subjected to analysis. The start of the survey, including the DCE, was at the end of July 2024. Conclusions: The results of the research project represent the first attempt to create a comprehensive user-oriented requirement profile for the development of sepsis-specific AI-based CDSS. In addition, general recommendations are derived, in order to reduce barriers in the development and implementation of AI-based CDSS. The findings of this research project have the potential to facilitate the integration of AI-based CDSS into standard care in the long term. International Registered Report Identifier (IRRID): DERR1-10.2196/62704
- 30 January 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e62704
Open AccessUser-Oriented Requirements for Artificial Intelligence–Based Clinical Decision Support Systems in Sepsis: Protocol for a Multimethod Research Project
Background: Artificial intelligence (AI)–based clinical decision support systems (CDSS) have been developed for several diseases. However, despite the potential to improve the quality of care and thereby positively impact patient-relevant outcomes, the majority of AI-based CDSS have not been adopted in standard care. Possible reasons for this include barriers in the implementation and a nonuser-oriented development approach, resulting in reduced user acceptance. Objective: This research project has 2 objectives. First, problems and corresponding solutions that hinder or support the development and implementation of AI-based CDSS are identified. Second, the research project aims to increase user acceptance by creating a user-oriented requirement profile, using the example of sepsis. Methods: The research project is based on a multimethod approach combining (1) a scoping review, (2) focus groups with physicians and professional caregivers, and (3) semistructured interviews with relevant stakeholders. The research modules mentioned provide the basis for the development of a (4) survey, including a discrete choice experiment (DCE) with physicians. A minimum of 6667 physicians with expertise in the clinical picture of sepsis are contacted for this purpose. The survey is followed by the development of a requirement profile for AI-based CDSS and the derivation of policy recommendations for action, which are evaluated in a (5) expert roundtable discussion. Results: The multimethod research project started in November 2022. It provides an overview of the barriers and corresponding solutions related to the development and implementation of AI-based CDSS. Using sepsis as an example, a user-oriented requirement profile for AI-based CDSS is developed. The scoping review has been concluded and the qualitative modules have been subjected to analysis. The start of the survey, including the DCE, was at the end of July 2024. Conclusions: The results of the research project represent the first attempt to create a comprehensive user-oriented requirement profile for the development of sepsis-specific AI-based CDSS. In addition, general recommendations are derived, in order to reduce barriers in the development and implementation of AI-based CDSS. The findings of this research project have the potential to facilitate the integration of AI-based CDSS into standard care in the long term. International Registered Report Identifier (IRRID): DERR1-10.2196/62704
- Open Access
- 15 December 2024
- Published by Elsevier in EBioMedicine
- Vol. 111, 105508
Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohort
- 15 December 2024
- Published by Elsevier in EBioMedicine
- Vol. 111, 105508
Open AccessMortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohort
- Open Access
Employing artificial intelligence for optimising antibiotic dosages in sepsis on intensive care unit: a study protocol for a prospective observational study (KI.SEP)
Introduction In sepsis treatment, achieving and maintaining effective antibiotic therapy is crucial. However, optimal antibiotic dosing faces challenges due to significant variability among patients with sepsis. Therapeutic drug monitoring (TDM), the current gold standard, lacks initial dosage adjustments and global availability. Even with daily TDM, antibiotic serum concentrations (ASCs) often deviate from the therapeutic range. This study addresses these challenges by developing machine learning (ML)-based ASC prediction models capable of handling variable data input and encompassing diverse clinical, laboratory, microbiological and proteomic parameters without the need for daily TDM. Methods This prospective observational study is conducted in a German university hospital intensive care unit. Eligible sepsis patients receive continuous antibiotic therapy with piperacillin/tazobactam (n=100) or meropenem (n=100) within 24 hours. Exclusion criteria include refusal, pregnancy, lactation and severe anaemia (haemoglobin Ethics and dissemination The study received approval from the Ethics Committee of the Medical Faculty of Ruhr-University Bochum (No. 23-7905). Findings will be disseminated through open-access publication in a peer-reviewed journal and social media channels. Trial registration number DRKS00032970.
Open AccessEmploying artificial intelligence for optimising antibiotic dosages in sepsis on intensive care unit: a study protocol for a prospective observational study (KI.SEP)
Introduction In sepsis treatment, achieving and maintaining effective antibiotic therapy is crucial. However, optimal antibiotic dosing faces challenges due to significant variability among patients with sepsis. Therapeutic drug monitoring (TDM), the current gold standard, lacks initial dosage adjustments and global availability. Even with daily TDM, antibiotic serum concentrations (ASCs) often deviate from the therapeutic range. This study addresses these challenges by developing machine learning (ML)-based ASC prediction models capable of handling variable data input and encompassing diverse clinical, laboratory, microbiological and proteomic parameters without the need for daily TDM. Methods This prospective observational study is conducted in a German university hospital intensive care unit. Eligible sepsis patients receive continuous antibiotic therapy with piperacillin/tazobactam (n=100) or meropenem (n=100) within 24 hours. Exclusion criteria include refusal, pregnancy, lactation and severe anaemia (haemoglobin Ethics and dissemination The study received approval from the Ethics Committee of the Medical Faculty of Ruhr-University Bochum (No. 23-7905). Findings will be disseminated through open-access publication in a peer-reviewed journal and social media channels. Trial registration number DRKS00032970.
- Open Access
- 5 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Improving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems.
- 5 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving AI-Based Clinical Decision Support Systems and Their Integration Into Care From the Perspective of Experts: Interview Study Among Different Stakeholders (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Artificial intelligence (AI)–based systems are receiving increasing attention in the health care sector. While the use of AI is well advanced in some medical applications, such as image recognition, it is still in its infancy in others, such as clinical decision support systems (CDSS). Examples of AI-based CDSS can be found in the context of sepsis prediction or antibiotic prescription. Scientific literature indicates that such systems can support physicians in their daily work and lead to improved patient outcomes. Nevertheless, there are various problems and barriers in this context that should be considered. Objective: This study aimed to identify opportunities to optimize AI-based CDSS and their integration into care from the perspective of experts. Methods: Semistructured web-based expert interviews were conducted. Experts representing the perspectives of patients; physicians; caregivers; developers; health insurance representatives; researchers (especially in law and IT); and experts in regulation, market admission and quality management or assurance, and ethics were included. The conversations were recorded and transcribed. Subsequently, a qualitative content analysis was performed. The different approaches to improvement were categorized into groups (“technology,” “data,” “users,” “studies,” “law,” and “general”). These also served as deductive codes. Inductive codes were determined within an internal project workshop. Results: In total, 13 individual and 2 double interviews were conducted with 17 experts. A total of 227 expert statements were included in the analysis. Suggestions were heterogeneous and concerned improvements: (1) in the systems themselves (eg, implementing comprehensive system training involving [future] users; using a comprehensive and high-quality database; considering usability, transparency, and customizability; preventing automation bias through control mechanisms or intelligent design; conducting studies to demonstrate the benefit of the system), (2) on the user side (eg, training [future] physicians could contribute to a more positive attitude and to greater awareness and questioning decision supports suggested by the system and ensuring that the use of the system does not lead to additional work), and (3) in the environment in which the systems are used (eg, increasing the digitalization of the health care system, especially in hospitals; providing transparent public communication about the benefits and risks of AI; providing research funding; clarifying open legal issues, eg, those related to liability; and standardizing and consolidating various approval processes). Conclusions: This study offers several possible strategies for improving AI-based CDSS and their integration into health care. These were found in the areas of “technology,” “data,” “users,” “studies,” “law,” and “general.” Systems, users, and the environment should be taken into account to ensure that the systems are used safely, effectively, and sustainably. Further studies should investigate both the effectiveness of strategies to improve AI-based CDSS and their integration into health care and the accuracy of their match to specific problems.
- Open Access
- 13 July 2024
- Published by Elsevier in Annals of Intensive Care
- Vol. 14 (1) , 111-13
Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7
- 13 July 2024
- Published by Elsevier in Annals of Intensive Care
- Vol. 14 (1) , 111-13
Open AccessPredictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7